stockrow
Friday 6 November 2026
Export MMED’s income statement to Excel — free account
MiniMed Group, Inc.
MMED Healthcare Medical Instruments & Supplies
MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.
17.45
0.71
−3.91%
Follow MMED
Alert me
MiniMed Group, Inc. (MMED) Operating cash flow
MiniMed Group, Inc.'s operating cash flow for fiscal 2026 was −$197.0M, compared with $140.0M in fiscal 2025. Over the twelve months to 31 July 2026 it was −$134.0M. MiniMed Group, Inc. ranks 51st of 51 Medical Instruments & Supplies companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2026 | −$197.0M | — |
| FY2025 | $140.0M | 241.46% |
| FY2024 | $41.0M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jul 2026 | −$49.0M | — |
| Jan 2026 | −$27.0M | — |
| Jul 2025 | −$141.0M | — |
| Apr 2025 | $83.0M | 45.61% |
| 2 more quarters | Free account |
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| BLCO Bausch + Lomb Corporation compare | $554.0M |
| NVST Envista Holdings Corporation compare | $301.8M |
| STVN Stevanato Group S.p.A. compare | $289.2M |
| ICUI ICU Medical, Inc. compare | $279.2M |
| MMSI Merit Medical Systems, Inc. compare | $273.7M |
| TFX Teleflex Incorporated compare | $129.3M |
| ATRC AtriCure, Inc. compare | $68.5M |
| PLSE Pulse Biosciences, Inc compare | −$63.3M |
| MMED MiniMed Group, Inc. | −$134.0M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on MMED
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Shares outstanding
- Book value per share
- The full statement